Benkowitz Michael

President And COO

1 company

Average

Trades Analyzed

12M Win Rate

8.7%

Avg 3M Return

+1.1%

Avg 12M Return

-28.6%

Benkowitz Michael is a President And COO at UNITED THERAPEUTICS Corp. Recent SEC Form 4 filings include 0 buys and 116 sells.

Holdings by Company

UTHRFeb 23, 2026

Current Shares0

Value-

Net Activity-547,194

Bought: 0Sold: 547.2K

Showing 10 filings (page 2)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Dec 1, 2025	UTHR United Therapeutics Corp	President And COO	Sale+OE	22,500	$479.91	$10,798,079.12	-29.0%	+7.1%	-
Sep 22, 2025	UTHR United Therapeutics Corp	President And COO	Sale+OE	22,500	$416.35	$9,367,953.75	-100%	+23.9%	-
Sep 15, 2025	UTHR United Therapeutics Corp	President And COO	Sale+OE	22,500	$400.56	$9,012,624.13	-21.9%	+24.1%	-
Sep 9, 2025	UTHR United Therapeutics Corp	President And COO	Sale+OE	16,375	$395.82	$6,481,612.42	-51.9%	+18.7%	-
Sep 2, 2025	UTHR United Therapeutics Corp	President And COO	Sale+OE	21,961	$418.04	$9,180,616.90	-27.5%	+18.6%	-
Mar 10, 2025	UTHR United Therapeutics Corp	President And COO	Sale+OE	2,000	$320.09	$640,183.75	-25.1%	+3.3%	+68.7%
Mar 3, 2025	UTHR United Therapeutics Corp	President And COO	Sale+OE	9,679	$311.99	$3,019,735.65	-27.0%	+5.0%	+60.8%
Feb 24, 2025	UTHR United Therapeutics Corp	President And COO	Sale+OE	10,000	$360.76	$3,607,554.55	-34.8%	-12.1%	+32.1%
Feb 18, 2025	UTHR United Therapeutics Corp	President And COO	Sale+OE	6,780	$371.18	$2,516,630.19	-17.6%	-18.1%	+27.7%
Feb 10, 2025	UTHR United Therapeutics Corp	President And COO	Sale+OE	10,000	$348.06	$3,480,642.28	-34.9%	-10.1%	+36.9%